Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

European Journal of Pediatrics

Volumn 161, Issue 11, 2002, Pages 581-587

  Avdicová, Mária ^a   Prikazský, Viktor ^a   Hudecková, Henrieta ^a   Schuerman, Lode ^b   Willems, Paul ^b  

^a State Institute of Public Health Slovakia   (Slovakia)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Acellular pertussis; Combined paediatric vaccines; Haemophilus influenzae b; Hepatitis B; Inactivated polio vaccine

Indexed keywords

ACELLULAR VACCINE; ANTIGEN; DIPHTHERIA TETANUS VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; POLYRIBOSYL RIBITOL PHOSPHATE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIPHTHERIA; DRUG SAFETY; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFANT; INFLUENZA; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL ANALYSIS; TETANUS; VACCINATION;

DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; POLYSACCHARIDES, BACTERIAL; VACCINES, COMBINED;

EID: 0036460651     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-002-1079-5     Document Type: Article

References (31)

1. Andre FE (1999) Development and clinical application of new polyvalent combined paediatric vaccines. Vaccine 17: 1620-1627
2. Blatter MM, Reisinger KS, Terwelp DR, DelBuono FJ, Howe BJ (1998) Immunogenicity of a combined diphtheria-tetanus-acellular pertussis (DT-tricomponent Pa)-hepatitis B (HB)-inactivated poliovirus (IPV) admixed with Haemophilus influen-zae type b (Hib) vaccine in infants. Pediatr Res 43: 141A
3. Cherry JD, Olin P (1999) The science and fiction of pertussis vaccines. Pediatrics 104: 1381-1383
4. Cherry JD, Gornbein J, Heininger U, Stehr K (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16: 1901-1906
5. Dagan R, Igbaria K, Piglansky L, Melamed R, Willems P, Grossi A, Kaufhold A (1997) Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine. Pediatr Infect Dis J 16: 1113-1121
6. Decker MD, Edwards KM (2000) Combination vaccines: Problems and promise. J Pediatr 137: 291-295
7. Deutsch J, Haschke F, Stógmann W, Willems P, Bogaerts H, Kaufhold A (1998) Evidence that a 2-Dose Primary Vaccination Course of a Combined DTPa-Hib Vaccine Induces Immunological Memory Relevant for Protection Against Haemophilus Influenzae Type B Disease. ICAAC Abstract G-33
8. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA (1999) Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 354: 2063-2068
9. Goldblatt D, Richmond P, Millard E, Thornton C, Miller E (1999) The induction of immunological memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus and pertussis vaccine combination. J Infect Dis 180: 538-541
10. Goldfarb J, Baley J, Medendorp SV, Seto D, Garcia H, Toy P, Watson B, Gooch MW, Krause D (1994) Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates. Pediatr Infect Dis J 13: 18-22
11. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi-Degli-Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SGF (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 334: 341-348
12. Gylca R. Glyca V, Benes O, Melnic A, Chicu V, Weisbecker C, Willems P, Kaufhold A (2000) A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth. Vaccine 19: 825-833
13. Hadler SC (1994) Cost benefit of combining antigens. Biologicals 22: 415-418
14. Halperin SA, King J, Law B, Mills E, Willems P (1999) Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Clin Infect Dis 28: 995-1001
15. Heath PT, Booy R, Azzopardi HJ, Slack MPE, Bowen-Morris J, Ramsay ME, Decks JJ, Moxon ER (2000) Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 284: 2334-2340
16. Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH (1999) Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B antigen. Hepatology 29: 954-959
17. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (1998) Statistical principles for clinical trials. Step 4. http://www.fda.gov/cder/guidance/guidance.htm
18. Miyamura K, Nisho S Ito A, Murata R, Kono R (1974) Micro cell culture method for determination of diphtheria toxin and antitoxin titers using VERO cells: I. Studies on factors a3ecting the toxin and antitoxin titration. J Biol Stand 2: 189-201
19. Miyamura K, Nisho S Ito A, Murata R, Kono R (1974) Micro cell culture method for determination of diphtheria toxin and antitoxin titers using VERO cells: II. Comparison with rabbit skin method and practical application for seroepidemiological studies. J Biol Stand 2: 203-209
20. Pichichero ME, Passador S (1998) Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine. Clin Infect Dis 25: 1378-1384
21. Poolman J, Kaufhold A, De Grave D, Goldblatt D (2001) Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine 19: 2280-2285
22. Recommendations of the Advisory Committee on Immunization Practices (ACIP) (1996) Update: Vaccine side-effects, adverse reactions, contraindications, and precautions. MMWR Morb Mortal Wkly Rep 45: 1-35
23. Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A and the Stage III Working Group (2001) Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: The Italian experience. Pediatrics108: e81 http://www.pediatrics.org/cgi/content/full/108/5/e81
24. Schmitt HJ, Wirsing von Konig CH, Neiss A, Bogaerts H, Bock HL, Schulte-Wissermann H, Gahr M, Schult R, Folkens JU, Rauh W, Clemens R (1996) Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275: 37-41.
25. Schmitt HJ, Knuf M, Ortiz E, Sanger R, Uwamwezi MC, Kaufhold A (2000) Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J Pediatr 137: 304-312
26. Schmitt HJ, Von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J (2001) Haemophilus influenzae type b disease: Impact and effectiveness of diphtheria-tetanus-acellular pertussis (-inactivated polio)/H. influenzae type b combination vaccines. Pediatr Infect Dis J 20: 767-774
27. Storsaeter J, Hallander HO, Gustafsson L, Olin P (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16: 1907-1916
28. Tarranger J, Trollfors B, Knutsson N, Sundh V, Lagergard T, Ostergaard E (2000) Vaccination of infants with a four-dose and a three-dose vaccination schedule. Vaccine 18: 884-891
29. Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT (1990) Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 161: 487-492
30. World Health Organization (1996) Hepatitis B Vaccine - Making Global Progress. Expanded Program on Immunization (EPI) WHO Update
31. Zepp F, Schmitt HJ, Kaufhold A, Schuind A, Knuf M, Hab-ermehl P, Bogaerts H, Slaoui M, Clemens R (1997) Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: Plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 156: 18-24